58.50
-1.30
(-2.17%)
At close: 1:30:01 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,921,187.00
1,755,567.00
2,210,589.00
1,849,924.00
1,668,586.00
Cost of Revenue
1,124,606.00
1,039,917.00
1,206,463.00
1,066,793.00
919,461.00
Gross Profit
796,581.00
715,650.00
1,004,126.00
783,131.00
749,125.00
Operating Expense
922,887.00
765,503.00
843,122.00
728,399.00
704,720.00
Operating Income
-126,306.00
-49,853.00
161,004.00
54,732.00
44,405.00
Net Non Operating Interest Income Expense
-55,662.00
-43,915.00
-29,705.00
-18,338.00
-20,237.00
Pretax Income
-164,133.00
-31,875.00
86,483.00
74,585.00
31,111.00
Tax Provision
-81,494.00
-38,406.00
-5,337.00
-14,740.00
-32,409.00
Net Income Common Stockholders
-83,241.00
6,209.00
91,025.00
87,413.00
62,434.00
Diluted NI Available to Com Stockholders
-83,241.00
6,209.00
91,025.00
87,413.00
62,434.00
Basic EPS
-1.36
0.10
1.50
1.45
1.06
Diluted EPS
-1.36
0.10
1.48
1.44
1.03
Basic Average Shares
62,892.38
60,757.00
60,533.00
60,078.00
59,176.00
Diluted Average Shares
63,387.38
61,252.00
61,424.00
60,827.00
60,376.00
Total Expenses
2,047,493.00
1,805,420.00
2,049,585.00
1,795,192.00
1,624,181.00
Net Income from Continuing & Discontinued Operation
-83,241.00
6,209.00
91,025.00
87,413.00
62,434.00
Normalized Income
-73,001.00
-23,002.20
114,694.60
70,963.40
81,061.20
Interest Income
4,890.00
4,319.00
943.00
713.00
1,315.00
Interest Expense
60,552.00
48,234.00
30,648.00
19,051.00
21,552.00
Net Interest Income
-55,662.00
-43,915.00
-29,705.00
-18,338.00
-20,237.00
EBIT
-103,581.00
16,359.00
117,131.00
93,636.00
52,663.00
EBITDA
73,275.00
179,781.00
270,363.00
248,293.00
216,145.00
Reconciled Cost of Revenue
1,124,606.00
1,039,917.00
1,206,463.00
1,066,793.00
919,461.00
Reconciled Depreciation
176,856.00
163,422.00
153,232.00
154,657.00
163,482.00
Net Income from Continuing Operation Net Minority Interest
-83,241.00
6,209.00
91,025.00
87,413.00
62,434.00
Total Unusual Items Excluding Goodwill
-12,800.00
36,514.00
-29,587.00
20,562.00
-23,284.00
Total Unusual Items
-12,800.00
36,514.00
-29,587.00
20,562.00
-23,284.00
Normalized EBITDA
86,075.00
143,267.00
299,950.00
227,731.00
239,429.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-2,560.00
7,302.80
-5,917.40
4,112.40
-4,656.80
12/31/2020 - 12/23/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4771.TW Vizionfocus Inc.
161.00
-0.62%
1752.TW Nang Kuang Pharmaceutical Co., Ltd.
41.35
-0.24%
6499.TWO Medeon Biodesign, Inc.
37.70
-0.40%
4126.TWO Pacific Hospital Supply Co., Ltd
93.10
-0.32%
6782.TW Visco Vision Inc.
158.50
-2.46%
4111.TWO Chi Sheng Pharma & Biotech Co., Ltd
28.50
-0.70%
6527.TWO Crystalvue Medical Corporation
84.40
-0.71%
1783.TW Maxigen Biotech Inc.
49.30
-5.37%
4116.TWO BenQ Medical Technology Corporation
45.40
-0.11%
6491.TW Pegavision Corporation
357.00
+0.14%